PRFX
NASDAQ · Pharmaceuticals
Prf Technologies Ltd
$0.87
+0.11 (+14.77%)
Open$0.89
Previous Close$0.76
Day High$0.89
Day Low$0.76
52W High$7.95
52W Low$0.64
Volume—
Avg Volume455.8K
Market Cap2.52M
P/E Ratio—
EPS$-9.71
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,273.3% upside
Current
$0.87
$0.87
Target
$11.96
$11.96
$8.59
$11.96 avg
$16.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 75.9K | 3.33M | 3.45M |
| Net Income | -21,642,306 | 722.6K | 805.0K |
| Profit Margin | -28,458.8% | 21.7% | 23.3% |
| EBITDA | -19,517,323 | 1.33M | 1.25M |
| Free Cash Flow | — | 449.2K | 396.5K |
| Rev Growth | — | -7.5% | +9.4% |
| Debt/Equity | — | 0.57 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |